Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide and Dexamethasone With or Without High-dose Melphalan in Multiple Myeloma
NCT01090089Phase 3Completed
- Sponsor
- GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie
- Start
- Mar 2010
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lenalidomide, melphalan in multiple myeloma (MM), sponsored by GMIHO Gesellschaft für Medizinische Innovation - Hämatologie und Onkologie. Started Mar 2010; status: completed.
02
Drugs
lenalidomidemelphalan
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01090089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090089.